PK
`I<=oa, mimetypeapplication/epub+zipPK
QfQ META-INF/PK
6IIkգ META-INF/container.xml
PK
3TfQ OPS/PK
lfQa' ' OPS/content.opf
Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia
9 Pages
Andrea Marcellusi
Chiara Bini
Maria A Rotundo
Rosario Cultrera
Francesco S Mennini
AboutScience
© 2020 The Authors
ISSN 2283-5733
it
2020-11-06
2020-11-06T12:10:00Z
PK
/TfQ OPS/images/PK
2NgO&H